References
- Gotham A-M, Brown RG, Marsden CD. Depression in Parkinson–s disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 1986;49:381–9.
- Berrios GE, Campbell C, Politynska BE. Auto-nomic failure, depression and anxiety in Parkinson–s disease. Br J Psychiatry 1995;166:789–92.
- Cummings JL. Depression and Parkinson–s disease: a review. Am J Psychiatry 1992;149:443–54.
- World Health Organization. International classification of disease, 10th rev. Mental and behavioural disorders: diagnostic criteria for research. Geneva: World Health Organization; 1993.
- Mayeux R. Depression in the patients with Parkinson–s disease. J Clin Psychiatry 1990;51(Suppl 7):20–3.
- Strang RR. Imipramine in treatment of Parkinson-ism: a double-blind placebo study. Br Med J 1965;2:33–4.
- Laitinen L. Desipramine in treatment of Parkinson–s disease. Acta Neurol Scand 1969;45:109–13.
- Andersen J, Aabro E, Gulmann N, Hjelmsted A, Pedersen HE. Antidepressive treatment in Parkinson–s disease. A controlled trial of the effect of nortriptyline in patients with Parkinson–s disease treated with L-dopa. Acta Neurol Scand 1980;62:210–9.
- Bech P. The Bech Hamilton and Zung Scales for mood disorders: screening and listening, 2nd rev. Berlin: Springer Verlag; 1996.
- Mayeux R, Stern Y, Sano M, Williams JBW, Cote LJ. The relationship of serotonin to depression in Parkinson–s disease. Mov Disord 1988;3:237–44.
- Agid Y, Cervera P, Hirsch E, Javoy-Agid F, Lehericy S, Raisman R, et al. Biochemistry of Parkinson–s disease 28 years later: a critical review. Mov Disord 1989;4 (Suppl 1):1126–44.
- Paykel ES. Use of the Hamilton Depression Scale in general practice. In: Bech P, Coppen A, editors. The Hamilton Scales. Berlin: Springer; 1990. pp. 40–7.
- Fuglum E, Rosenberg C, Damsbo N, Stage K, Lauritzen L, Bech P. Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs patients treated by their family doctors. Acta Psychiatr Scand 1996;94:18–25.
- Guy W. ECDEU Assessment manual for psy-chopharmacology; 1976.
- Fahn S, Elton RL, Members of the UPDRS Development Committee. Unified Parkinson–s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, editors. Recent developments in Parkinson–s disease, Vol. 2. Florham Park (NJ): Macmillan Health Care Information; 1987. p. 153– 64.
- Lingj–rde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect ratingscale. Acta Psychiatr Scand 1987;76 (Suppl 334):1–99.
- Suchowersky O, deVries JD. Interaction of fluox-etine and selegiline. Can J Psychiatr 1990;35:571–2.
- Siegel S. Non-parametric statistics. New York: McGraw Hill; 1956.
- Bech P. Acute therapy of depression. J Clin Psychiatry 1993;54 (Suppl 8):18–27.
- Mannion L, O–Sullivan S, Carney PA, Moran J. Parkinson–s disease exacerbated by paroxetine. Ir J Psych Med 1997;14:74–5.
- Steur ENHJ. Increase of Parkinson disability after fluoxetine medication. Neurology 1993;43:211–3.
- Lauritzen L, Bjerg Bendsen L, Vilmar T, Bjerg Bendsen E, Lunde M, Bech P. Poststroke depression: combined treatment with imipramine or de-sipramine and mianserin. A controlled clinical study. Psychopharmacology 1994;114:119–22.
- Lange C. Periodische Depressionszusta–nde und ihre Pathogenesis auf dem Boden der harnsauren Diathese. Leipzig: Verlag von Leopold Voss; 1896 Danish version 1886.
- Angst J. Recurrent brief depression: a new concept of depression. Pharmacopsychiatry 1990;23:63–6.
- Stenager EN, Wermuth L, Stenager E, Boldsen J. Suicide in patients with Parkinson–s disease. An epidemiologic study. Acta Psychiatr Scand 1994;90:70–2.
- Montgomery DB, Roberts A, Green M, Boullock Baldwin D, Montgomery SA. Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Neurol Sci 1994;244:211–5.
- Montgomery D, Evans R, Montgomery SA. Pharmacological differences between brief and major depression. Eur Neuropsychopharmacol 1993;3 (Suppl 3):215.
- Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson–s disease. Arch Neurol 1996;53:175–9.
- Bech P. Depressive syndrome in Parkinson–s disease: clinical manifestations. In: Wolters EC, Scheltens P, editors. Mental dysfunction in Parkinson–s disease. Amsterdam: Vrije; 1993. pp. 315–24.